Neogenomics Inc (NEO) Implied Volatility Current

Tracking NEO implied volatility helps you identify when options premiums on Neogenomics Inc are historically cheap or expensive, and where the best trades are hiding. Neogenomics Inc implied volatility reflects the market's expectation of future price movement: when NEO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Neogenomics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For NEO, tracking metrics like NEO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on NEO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains.

The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where NEO implied volatility sits today versus where it has been. Our scanner ranks Neogenomics Inc implied volatility against its historical range, surfaces extremes in NEO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Neogenomics Inc IV is rich or cheap — measure it, then act on it.